Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI

NCT04063800 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT04063800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04063800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
June 26, 2018
Completion date
August 28, 2018
Enrollment
195 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic adenocarcinoma